Log in
Enquire now
‌

US Patent 10954287 Ras binding peptides and methods of use

Patent 10954287 was granted and assigned to Ra Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Ra Pharmaceuticals
Ra Pharmaceuticals
0
Current Assignee
Ra Pharmaceuticals
Ra Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
109542870
Patent Inventor Names
Douglas A. Treco0
Sylvia Tobe0
Yili Sun0
Zhong Ma0
Douangsone D. Vadysirisack0
Guo-Qing Tang0
Kathleen Seyb0
Kristopher Josephson0
...
Date of Patent
March 23, 2021
0
Patent Application Number
160937620
Date Filed
April 14, 2017
0
Patent Citations Received
‌
US Patent 12059413 Methods of inhibiting viruses using compositions targeting TSG101-ubiquitin interaction
0
Patent Primary Examiner
‌
Larry D Riggs, II
0
Patent abstract

The present invention provides Ras modulators including inhibitors and/or antagonists of Ras, Ras binding, and Ras-dependent cell signaling activity. Also provided are methods of utilizing the Ras modulators as therapeutics.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10954287 Ras binding peptides and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.